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Melanotic Neuroectodermal Tumor
Presenting as Endolymphatic Sac Tumor
Joseph Choy, BS1, Mehdi Abouzari, MD, PhD1, Hossein Mahboubi, MD, MPH1,
Mark E. Linskey, MD2, and Hamid R. Djalilian, MD1,3
Melanotic neuroectodermal tumors (MNTs) are rare neo-
plasms of neural crest cell origin that usually arise during
the first year of life with very few reported cases arising in
ages 4 to 69.1 These tumors most commonly present in the
maxilla but are also seen in the skull and mandible and
there have been cases reported in unusual regions such as
the testes and peripheral bones.1,2 Here, we report a very
rare manifestation of pediatric MNTs presenting as an endo-
lymphatic sac tumor.
A 7-year-old boy was referred to our neurotology clinic for
evaluation of right-sided hearing loss, revealed during hearing
screening at school. His parents noticed that he also had recur-
rent attacks of headache and dizziness, episodes of transient
vision blurriness, and intermittent epistaxis. Microscopic ear
examination revealed a small, nonpulsatile, pink middle ear
mass adherent to the tympanic membrane. Audiology testing
showed a right-sided severe to profound sensorineural hearing
loss. He had a normal past medical and developmental history
and his family history was negative for syndromic diseases.
Computed tomography (CT) scan of the temporal bone showed
widened right internal auditory canal and opacification of the
middle ear and mastoid as well as erosion along the petrous
bone adjacent to the endolymphatic sac (Figure 1). Magnetic
resonance imaging (MRI) scans revealed a mass centered in the
endolymphatic sac region with involvement of the internal
auditory canal, cochlea and vestibular structures, and the right
middle ear (Figure 2).
The patient underwent a transotic approach for the resec-
tion of a susceptible endolymphatic sac tumor. Intraopera-
tively, the tumor appeared melanotic (Figure 3) and had
spread to the vestibule and filled the posterior and superior
canals as well as cochlea and part of the internal auditory
canal. Microscopically the tumor showed foci of alveolar
growth pattern in the background of fibrous stroma at low
magnification and demonstrated a biphasic tumor with small
Figure 1. Computed tomography scan of the right temporal bone
without contrast shows internal auditory canal widened to 7 mm,
indicating an expansile mass with erosion along the posterior petrous
bone (A) and the cochlea (B).
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neuroblastic cells and large melanin-containing cells at high
magnification (Figure 4). Final pathological examination
revealed an MNT with extension into the bone. Postsurgical
CT and MRI scans at 3 months showed no evidence of recur-
rence. Patient’s recovery has been uneventful with no further
complications 1 year following the surgery.
Melanotic neuroectodermal tumors are rare neoplasms usu-
ally presenting in the first year of life with no gender predilec-
tion.1 These tumors have had different names in the past
including melanotic progonoma, melanotic adamantinoma, ret-
inal anlage tumor, and pigmented congenital epulis due to the
uncertainty of the tumors’ origin. Melanotic neuroectodermal
tumors are typically benign, although malignant transformation
can rarely occur.1 These tumors generally present in the cra-
niofacial region and, despite their benign nature, can display
rapid growth causing destruction of surrounding structures with
the need for possible reconstruction at the site of resection.3
Surgical resection of the tumor is the standard of care and is
mostly curative, but these tumors do have an overall recurrence
rate of 15% to 27%.3,4 Although these recurrence rates are
reported for a younger age range, this relatively high recurrence
rate warrants the need for long-term neuroimaging follow-ups
in these patients.
Endolymphatic sac tumors can easily be mistaken for
several different malignancies upon clinical presentation
because of their location and rarity of the tumor. These
tumors are locally aggressive and have been diagnosed
over a wide range of age from 15 to 77 years old. In our
patient, the location of the lesion, age at presentation, and
accompanying sensorineural hearing loss all contributed
to the initial clinical diagnosis of an endolymphatic sac
tumor. Final diagnosis of MNTs has to be approved
pathologically using staining for markers, such as synap-
tophysin, cytokeratin, and HMB-45.5 This case illustration
highlights the importance of considering MNT in the
differential diagnosis list of the craniofacial tumors
despite unusual location of the tumor and age range of
presentation.
Figure 3. Intraoperative melanotic appearance of the tumor (arrow).
Figure 4. Low magnification displays alveolar growth pattern in background of fibrous stroma (arrow; A). High magnification demonstrates
biphasic tumor with small neuroblastic (small arrow) and large melanin-containing cells (large arrow; B).
Figure 2. Axial T1-weighted postgadolinium MRI showing tumor in
the endolymphatic sac area with spread into the vestibule, cochlea,
and internal auditory canal. MRI indicates magnetic resonance imaging.
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